Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Work In Process: 2022-2024

Historic Work In Process for Fortress Biotech (FBIO) over the last 3 years, with Dec 2024 value amounting to $367,000.

  • Fortress Biotech's Work In Process fell 45.96% to $435,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $435,000, marking a year-over-year decrease of 45.96%. This contributed to the annual value of $367,000 for FY2024, which is 58.48% down from last year.
  • Per Fortress Biotech's latest filing, its Work In Process stood at $367,000 for FY2024, which was down 58.48% from $884,000 recorded in FY2023.
  • Fortress Biotech's Work In Process' 5-year high stood at $884,000 during FY2023, with a 5-year trough of $367,000 in FY2024.
  • Over the past 3 years, Fortress Biotech's median Work In Process value was $395,000 (recorded in 2022), while the average stood at $548,667.
  • As far as peak fluctuations go, Fortress Biotech's Work In Process skyrocketed by 123.80% in 2023, and later tumbled by 58.48% in 2024.
  • Over the past 3 years, Fortress Biotech's Work In Process (Yearly) stood at $395,000 in 2022, then soared by 123.80% to $884,000 in 2023, then plummeted by 58.48% to $367,000 in 2024.